In the past 2 years, the generalization of IL-6 testing has become more and more widespread around the world, especially in some developed regions such as the United States, Europe, and Japan, etc. In our country, many large hospitals and research institutes have incorporated IL-6 testing into their routine screening programs, especially in the fields of intensive care, infectious diseases, and autoimmune diseases. Here, IL6 is linked to autoimmune disease.